Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthetic multiepitope neoantigen DNA vaccine for personalized cancer immunotherapy
Xiaoyue Yang, Jiansheng Fan, Yue Wu, et al.
Nanomedicine Nanotechnology Biology and Medicine (2021) Vol. 37, pp. 102443-102443
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 111
Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell
Lu Diao, Mi Liu
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 71
Designing neoantigen cancer vaccines, trials, and outcomes
Nupur Biswas, Shweta Chakrabarti, Vijay Padul, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 45
Advancing personalized immunotherapy for melanoma: Integrating immunoinformatics in multi-epitope vaccine development, neoantigen identification via NGS, and immune simulation evaluation
Mohammad Javad Kamali, Mohammad Salehi, Mohsen Karami Fath
Computers in Biology and Medicine (2025) Vol. 188, pp. 109885-109885
Closed Access | Times Cited: 3
Plasmid DNA for Therapeutic Applications in Cancer
David Hernán Martínez-Puente, José J. Pérez‐Trujillo, Laura Mireya Zavala-Flores, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1861-1861
Open Access | Times Cited: 39
Advancements in the Treatment of Triple-Negative Breast Cancer: A Narrative Review of the Literature
Ian Landry, Vikram Sumbly, Mallorie Vest
Cureus (2022)
Open Access | Times Cited: 32
Neoantigens in precision cancer immunotherapy: from identification to clinical applications
Qiao Zhang, Qingzhu Jia, Jing Zhang, et al.
Chinese Medical Journal (2022) Vol. 135, Iss. 11, pp. 1285-1298
Open Access | Times Cited: 29
Application prospect of circular RNA-based neoantigen vaccine in tumor immunotherapy
Mohan Li, Yian Wang, Pan Wu, et al.
Cancer Letters (2023) Vol. 563, pp. 216190-216190
Closed Access | Times Cited: 20
Tumor neoantigens: Novel strategies for application of cancer immunotherapy
Hanyang Guan, Yue Wu, Lu Li, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 4, pp. 437-448
Open Access | Times Cited: 18
A Bioengineered Nanovesicle Vaccine Boosts T‐B cell Interaction for Immunotherapy of Echinococcus multilocularis
Xiaoyu An, Wei Xiang, Xue Liu, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 13
Closed Access | Times Cited: 8
Research progress of nanovaccine in anti-tumor immunotherapy
Min Yao, Xiyu Liu, Zhangbo Qian, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 15
Nanotechnology-Based Approaches to Promote Lymph Node Targeted Delivery of Cancer Vaccines
Ruiqing He, Jie Zang, Yuge Zhao, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 8, Iss. 2, pp. 406-423
Closed Access | Times Cited: 20
Recent advances in the liposomal nanovesicles based immunotherapy in the treatment of cancer: A review
Yahya Alhamhoom, Greeshma Kakinani, Mohamed Rahamathulla, et al.
Saudi Pharmaceutical Journal (2022) Vol. 31, Iss. 2, pp. 279-294
Open Access | Times Cited: 20
Immunotherapeutic Approaches in Ovarian Cancer
Hyunho Yoon, Ayoung Kim, Hoon Jang
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 2, pp. 1233-1249
Open Access | Times Cited: 12
Targeting Tumor Heterogeneity with Neoantigen-Based Cancer Vaccines
Saranya Pounraj, Shuxiong Chen, Linlin Ma, et al.
Cancer Research (2023) Vol. 84, Iss. 3, pp. 353-363
Closed Access | Times Cited: 11
Nanomaterial Delivery Vehicles for the Development of Neoantigen Tumor Vaccines for Personalized Treatment
Xiaoyu Huang, Xiaolong Zhu, Huan Yang, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1462-1462
Open Access | Times Cited: 4
Smart Lipid-Based Nanosystems for Therapeutic Immune Induction against Cancers: Perspectives and Outlooks
Seth‐Frerich Fobian, Ziyun Cheng, Timo L.M. ten Hagen
Pharmaceutics (2021) Vol. 14, Iss. 1, pp. 26-26
Open Access | Times Cited: 26
Tailoring Nanovectors for Optimal Neoantigen Vaccine Efficacy
Youshi Zheng, Binghe Wang, Zhixiong Cai, et al.
Journal of Materials Chemistry B (2025)
Closed Access
Neoantigen vaccines: advancing personalized cancer immunotherapy
Alaa A. A. Aljabali, Yassmen Hamzat, Alaa Alqudah, et al.
Exploration of Immunology (2025) Vol. 5
Open Access
State-of-the-Art Review on Liposomes as Versatile Cancer Vaccine Delivery Systems
Abulfazl Vatankhah, Fatemeh Oroojalian, Sepehr Hoseinzadeh Moghaddam, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106975-106975
Closed Access
Advancements in the use of cancer nanovaccines: Comprehensive insights with focus on lung and colon cancer
Qian Li, Jingjuan Shi, Caixia Pei, et al.
Nanotechnology Reviews (2025) Vol. 14, Iss. 1
Open Access
Advances in Cancer Nanovaccines: Harnessing Nanotechnology for Broadening Cancer Immune Response
Qian‐Ting Wang, Yixuan Liu, Jie Wang, et al.
ChemMedChem (2023) Vol. 18, Iss. 13
Closed Access | Times Cited: 7
Personalized Neoantigen DNA Cancer Vaccines: Current Status and Future Perspectives
Nadia Viborg, Daniela Kleine‐Kohlbrecher, Birgitte Rønø
Journal of Cellular Immunology (2024) Vol. 6, Iss. 1, pp. 15-24
Open Access | Times Cited: 2
Immunotherapy for small cell lung cancer: the current state and future trajectories
Min Qiang, Hongyang Liu, Lei Yang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Circular RNA vaccines: Pioneering the next-gen cancer immunotherapy
Uddalak Das, Soupayan Banerjee, Meghna Sarkar, et al.
Cancer Pathogenesis and Therapy (2024)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top